Brief reports| Volume 56, ISSUE 11, P901-904, December 01, 2004

Anxiety-like state associates with taste to produce conditioned taste aversion


      The interactions among experience, emotion, and memory are considered to be instrumental in the ontogeny and maintenance of acquired emotional and behavioral disorders (e.g., phobias). Here we address the question whether an anxiety-like state can associate with taste to produce conditioned taste aversion (CTA).


      We have used an anxiogenic agent, the 5-HT2C receptor agonist meta-chlorophenylpiperazine (mCPP), to induce an anxiety-like emotional state in rats after consumption of an unfamiliar tastant.


      The anxiogenic agent induced CTA. The mCPP-induced CTA could be prevented by concomitant administration of ethanol, which is known to reverse mCPP-induced anxiety-like behavior, at a concentration that had no effect on CTA memory. In contrast, ethanol did not prevent LiCl-induced CTA. Administration of mCPP before the consumption of the tastant had no effect on the preference for that tastant.


      Taken together, these results indicate that anxiety-like state can serve as the unconditioned stimulus in CTA training. This finding may be relevant to the ontogeny of pathologies involving food aversion.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Akirav I.
        • Richter-Levin G.
        Biphasic modulation of hippocampal plasticity by behavioral stress and basolateral amygdala stimulation in the rat.
        J Neurosci. 1999; 19: 10530-10535
        • Bagdy G.
        • Graf M.
        • Anheuer Z.E.
        • Modos E.A.
        • Kantor S.
        Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
        Int J Neuropsychopharmacol. 2001; 4: 399-408
        • Bahar A.
        • Samuel A.
        • Hazvi S.
        • Dudai Y.
        The amygdalar circuit that acquires taste aversion memory differs from the circuit that extinguishes it.
        Eur J Neurosci. 2003; 17: 1527-1530
        • Bilkei-Gorzo A.
        • Gyertyan I.
        • Levay G.
        mCPP-induced anxiety in the light-dark box in rats—a new method for screening anxiolytic activity.
        Psychopharmacology. 1998; 136: 291-298
        • Blair R.
        • Amit Z.
        Morphine conditioned taste aversion reversed by periaqueductal gray lesions.
        Pharmacol Biochem Behav. 1981; 15: 651-653
        • Bourin M.
        • Baker G.B.
        • Bradwejn J.
        Neurobiology of panic disorders.
        J Psychosom Res. 1998; 44: 163-180
        • Bures J.
        • Bermudez-Rattoni F.
        • Yamamoto T.
        The CTA paradigm.
        in: Bures J. Bermudez-Rattoni F. Yamamoto T. Conditioned Taste Aversion, Memory of a Special Kind. Oxford University Press, Oxford1998: 1-25
        • Campbell B.M.
        • Merchant K.M.
        Serotonin 2C receptors within the basolateral amygdale induce acute fear-like responses in an open-field environment.
        Brain Res. 2003; 993: 1-9
        • Charney D.S.
        • Woods S.W.
        • Goodman W.K.
        • Heninger G.R.
        Serotonin function in anxiety. II: Effects of the serotonin agonist mCPP in panic disorder patients and healthy subjects.
        Psychopharmacology. 1987; 92: 14-24
        • Costall B.
        • Kelly M.E.
        • Naylor R.J.
        The anxiolytic and anxiogenic actions of ethanol in a mouse model.
        J Pharm Pharmacol. 1988; 40: 197-202
        • Erzegovesi S.
        • Martucci L.
        • Henin M.
        • Bellodi L.
        Low versus standard dose mCPP challenge in obsessive-compulsive patients.
        Neuropsychopharmacology. 2001; 24: 31-36
        • File S.E.
        What can be learned from the effects of benzodiazepines on exploratory behavior?.
        Neurosci Behav Rev. 1985; 9: 45-54
        • Garcia J.
        • Kimmeldorf D.J.
        • Koelling R.A.
        Conditioned aversion to saccharin resulting from exposure to gamma radiation.
        Science. 1955; 122: 157-158
        • Grillon C.
        Startle reactivity and anxiety disorders.
        Biol Psychiatry. 2002; 52: 958-975
        • Gross C.
        • Zhuang X.
        • Stark K.
        • Ramboz S.
        • Oosting R.
        • Kirby L.
        • et al.
        Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult.
        Nature. 2002; 416: 396-400
        • Kennett G.A.
        • Whitton P.
        • Shah K.
        • Curzon G.
        Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists.
        Eur J Pharmacol. 1989; 164: 445-454
        • Kennett G.A.
        • Wood M.D.
        • Glen A.
        • Grewal S.
        • Forbes I.
        • Gadre A.
        • Blackburn T.P.
        In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.
        Br J Pharmacol. 1994; 111: 797-802
        • Land C.
        • Spear N.E.
        Ethanol impairs memory of a simple discrimination in adolescent rats at doses that leave adult memory unaffected.
        Neurobiol Learn Mem. 2004; 81: 75-81
        • LeDoux J.E.
        Emotional memory systems in the brain.
        Behav Brain Res. 1993; 58: 69-79
        • LeDoux J.E.
        Fear and the brain.
        Biol Psychiatry. 1998; 44: 1229-1238
        • Leplow B.
        • Murphy R.
        • Nutzinger D.O.
        Specificity of conditional associative-learning deficits in obsessive-compulsive disorder (OCD) and non-OCD anxiety disorders.
        J Clin Exp Neuropsychol. 2002; 24: 792-805
        • Lesch K.P.
        Molecular foundation of anxiety disorders.
        J Neural Transm. 2001; 108: 717-746
        • Lesch K.P.
        • Bengel D.
        • Heils A.
        • Sabol S.Z.
        • Greenberg B.D.
        • Petri S.
        • et al.
        Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.
        Science. 1996; 274: 1527-1531
        • Marks I.
        Fears, Phobias and Rituals. Oxford University Press, New York1987
        • Milan M.J.
        The neurobiology and control of anxious states [review].
        Prog Neurobiol. 2003; 70: 83-244
        • Öhman A.
        Fear and anxiety as emotional phenomena.
        in: Lewis M. Haviland J.M. Handbook of the Emotions. Guilford Press, New York1992: 511-536
        • Rosenblum K.
        • Berman D.E.
        • Hazvi S.
        • Lamprecht R.
        • Dudai Y.
        NMDA receptor and the tyrosine phosphorylation of its 2B subunit in taste learning in the rat insular cortex.
        J Neurosci. 1997; 17: 5129-5135
        • Singewald N.
        • Salchner P.
        • Sharp T.
        Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs.
        Biol Psychiatry. 2003; 53: 275-283
        • Snyder S.H.
        Serotonin sustains serenity.
        Nature. 2002; 416: 377-380